BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 22156340)

  • 1. Size-dependent attenuation of TLR9 signaling by gold nanoparticles in macrophages.
    Tsai CY; Lu SL; Hu CW; Yeh CS; Lee GB; Lei HY
    J Immunol; 2012 Jan; 188(1):68-76. PubMed ID: 22156340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased intracellular TLR9 confers hyporesponsiveness of RAW264.7 cells to subsequent CpG ODN challenge.
    Wei L; Hong Z; Jiang Z; Guofu D; Hongwei C; Liangxi W; Yongling L; Bin L; Ping L
    Int Immunopharmacol; 2006 Jun; 6(6):935-46. PubMed ID: 16644479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis.
    Amcheslavsky A; Hemmi H; Akira S; Bar-Shavit Z
    J Bone Miner Res; 2005 Sep; 20(9):1692-9. PubMed ID: 16059640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chicken TLR21 acts as a functional homologue to mammalian TLR9 in the recognition of CpG oligodeoxynucleotides.
    Brownlie R; Zhu J; Allan B; Mutwiri GK; Babiuk LA; Potter A; Griebel P
    Mol Immunol; 2009 Sep; 46(15):3163-70. PubMed ID: 19573927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation.
    Li B; Zhang R; Li J; Zhang L; Ding G; Luo P; He S; Dong Y; Jiang W; Lu Y; Cao H; Zheng J; Zhou H
    Int Immunopharmacol; 2008 Mar; 8(3):379-89. PubMed ID: 18279792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG-oligodeoxynucleotide inhibits Smad-dependent bone morphogenetic protein signaling: effects on myeloma cell apoptosis and in vitro osteoblastogenesis.
    Nørgaard NN; Holien T; Jönsson S; Hella H; Espevik T; Sundan A; Standal T
    J Immunol; 2010 Sep; 185(6):3131-9. PubMed ID: 20702733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CpG oligonucleotides induce an immune response of odontoblasts through the TLR9, MyD88 and NF-kappaB pathways.
    He W; Yu Q; Zhou Z; Wang P
    Biochem Biophys Res Commun; 2010 Aug; 399(2):274-8. PubMed ID: 20655295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
    Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM
    J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG-ODN promotes phagocytosis and autophagy through JNK/P38 signal pathway in Staphylococcus aureus-stimulated macrophage.
    Wu HM; Wang J; Zhang B; Fang L; Xu K; Liu RY
    Life Sci; 2016 Sep; 161():51-9. PubMed ID: 27476088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of probiotics, probiotic DNA and the CpG oligodeoxynucleotides on ovalbumin-sensitized Brown-Norway rats via TLR9/NF-κB pathway.
    Zhong Y; Huang J; Tang W; Chen B; Cai W
    FEMS Immunol Med Microbiol; 2012 Oct; 66(1):71-82. PubMed ID: 22612777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR9 signaling failure renders Peyer's patch regulatory B cells unresponsive to stimulation with CpG oligodeoxynucleotides.
    Booth JS; Arsenault R; Napper S; Griebel PJ; Potter AA; Babiuk LA; Mutwiri GK
    J Innate Immun; 2010; 2(5):483-94. PubMed ID: 20551621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of toll-like receptor-9 induces matrix metalloproteinase-9 expression through Akt and tumor necrosis factor-alpha signaling.
    Lim EJ; Lee SH; Lee JG; Chin BR; Bae YS; Kim JR; Lee CH; Baek SH
    FEBS Lett; 2006 Aug; 580(18):4533-8. PubMed ID: 16870179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combination of Lox-1 and Nox1 regulates TLR9-mediated foam cell formation.
    Lee JG; Lim EJ; Park DW; Lee SH; Kim JR; Baek SH
    Cell Signal; 2008 Dec; 20(12):2266-75. PubMed ID: 18817866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CMRF-35-like molecule 3 preferentially promotes TLR9-triggered proinflammatory cytokine production in macrophages by enhancing TNF receptor-associated factor 6 ubiquitination.
    Wu Y; Zhu X; Li N; Chen T; Yang M; Yao M; Liu X; Jin B; Wang X; Cao X
    J Immunol; 2011 Nov; 187(9):4881-9. PubMed ID: 21940676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat shock up-regulates TLR9 expression in human B cells through activation of ERK and NF-kappaB signal pathways.
    Chen W; Wang J; An H; Zhou J; Zhang L; Cao X
    Immunol Lett; 2005 Apr; 98(1):153-9. PubMed ID: 15790521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific siRNA downregulated TLR9 and altered cytokine expression pattern in macrophage after CpG DNA stimulation.
    Qiao B; Li B; Yang X; Zhang H; Chu Y; Wang Y; Xiong S
    Cell Mol Immunol; 2005 Apr; 2(2):130-5. PubMed ID: 16191419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The newly identified CpG-N ODN208 protects mice from challenge with CpG-S ODN by decreasing TNF-alpha release.
    Wang L; Jiang W; Ding G; Cao H; Lu Y; Luo P; Zhou H; Zheng J
    Int Immunopharmacol; 2007 May; 7(5):646-55. PubMed ID: 17386412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic Human TLR9-LRR11 Peptide Attenuates TLR9 Signaling by Binding to and thus Decreasing Internalization of CpG Oligodeoxynucleotides.
    Pan X; Li B; Kuang M; Liu X; Cen Y; Qin R; Ding G; Zheng J; Zhou H
    Int J Mol Sci; 2016 Feb; 17(2):242. PubMed ID: 26907260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic methylated CpG ODNs are potent in vivo adjuvants when delivered in liposomal nanoparticles.
    Chikh G; de Jong SD; Sekirov L; Raney SG; Kazem M; Wilson KD; Cullis PR; Dutz JP; Tam YK
    Int Immunol; 2009 Jul; 21(7):757-67. PubMed ID: 19502586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulin is a soluble cofactor for toll-like receptor 9 signaling.
    Park B; Buti L; Lee S; Matsuwaki T; Spooner E; Brinkmann MM; Nishihara M; Ploegh HL
    Immunity; 2011 Apr; 34(4):505-13. PubMed ID: 21497117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.